Actively Recruiting
STREAM Observational Study on Treatment Outcomes for Relapsed or Refractory Acute Myeloid Leukemia Across Europe
Led by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS · Updated on 2026-10-27
4000
Participants Needed
41
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective observational study called STREAM that collects data from patients diagnosed with relapsed or refractory acute myeloid leukemia AML. This study aims to gather real-world information on treatment outcomes across Europe, including pediatric, adult, and elderly patients, as well as those with rare mutations or post-transplant relapse. The goal is to better understand the disease and support future clinical trials by monitoring various patient groups in different care settings. Participants will be registered into the STREAM platform where baseline and follow-up data will be recorded. Patients are followed according to standard clinical practice for up to 4 years. This study does not involve experimental treatments but collects detailed information on diagnosis methods, treatment options, and patient outcomes to evaluate overall survival and other clinical measures. During the study, researchers will track outcomes such as overall survival, remission rate, event-free survival, relapse-free survival, and transplant rate over 8 years. They will also analyze associations between clinical and molecular parameters and patient outcomes. Data collection includes medical records and follow-up visits based on routine care, supporting the development of future targeted therapies and clinical trials for relapsed or refractory AML.
CONDITIONS
Brief Title
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Research Team
O
Oriana Nanni
I
Impact-aml coord Impact-aml coord
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here